Indication:
Biliary adenocarcinoma, chronic lymphocytic leukemia, Esophageal and gastric cancer, non-Hodgkin lymphoma, Advanced ovarian and pancreatic cancer.
Dosage Forms:
50mg/vial
Biliary adenocarcinoma, chronic lymphocytic leukemia, Esophageal and gastric cancer, non-Hodgkin lymphoma, Advanced ovarian and pancreatic cancer.
Dosage Forms:
50mg/vial